Lawrence Biegelsen
Stock Analyst at Wells Fargo
(1.81)
# 3,307
Out of 5,044 analysts
56
Total ratings
52.78%
Success rate
-4.42%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lawrence Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Maintains: Overweight | $142 → $146 | $126.61 | +15.31% | 9 | Oct 16, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Equal-Weight | $172 → $184 | $184.21 | -0.11% | 5 | Aug 8, 2025 | |
| PODD Insulet | Maintains: Overweight | $330 → $350 | $324.34 | +7.91% | 5 | Aug 8, 2025 | |
| NPCE NeuroPace | Upgrades: Overweight | $16 → $20 | $10.62 | +88.32% | 7 | Mar 14, 2024 | |
| TNDM Tandem Diabetes Care | Maintains: Overweight | $166 → $82 | $15.10 | +443.05% | 5 | Aug 4, 2022 | |
| TFX Teleflex | Downgrades: Equal-Weight | $248 | $130.58 | +89.92% | 1 | Jul 29, 2022 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $350 → $339 | $545.39 | -37.84% | 2 | Apr 22, 2022 | |
| REE REE Automotive | Initiates: Underweight | $1.5 | $1.09 | +37.61% | 1 | Mar 25, 2022 | |
| LUNG Pulmonx | Maintains: Equal-Weight | $55 → $27 | $1.98 | +1,263.64% | 3 | Feb 24, 2022 | |
| ZBH Zimmer Biomet Holdings | Maintains: Underweight | $124 → $111 | $101.14 | +9.75% | 2 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $144 | $69.23 | +107.64% | 1 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $56 | $77.79 | -28.01% | 4 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $68 → $74 | $82.75 | -10.57% | 6 | Oct 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $77 | $82.19 | -6.72% | 3 | Apr 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $85 → $90 | $13.37 | +573.15% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | n/a | $62.75 | - | 1 | Dec 12, 2019 |
Abbott Laboratories
Oct 16, 2025
Maintains: Overweight
Price Target: $142 → $146
Current: $126.61
Upside: +15.31%
Becton, Dickinson and Company
Aug 8, 2025
Maintains: Equal-Weight
Price Target: $172 → $184
Current: $184.21
Upside: -0.11%
Insulet
Aug 8, 2025
Maintains: Overweight
Price Target: $330 → $350
Current: $324.34
Upside: +7.91%
NeuroPace
Mar 14, 2024
Upgrades: Overweight
Price Target: $16 → $20
Current: $10.62
Upside: +88.32%
Tandem Diabetes Care
Aug 4, 2022
Maintains: Overweight
Price Target: $166 → $82
Current: $15.10
Upside: +443.05%
Teleflex
Jul 29, 2022
Downgrades: Equal-Weight
Price Target: $248
Current: $130.58
Upside: +89.92%
Intuitive Surgical
Apr 22, 2022
Maintains: Overweight
Price Target: $350 → $339
Current: $545.39
Upside: -37.84%
REE Automotive
Mar 25, 2022
Initiates: Underweight
Price Target: $1.5
Current: $1.09
Upside: +37.61%
Pulmonx
Feb 24, 2022
Maintains: Equal-Weight
Price Target: $55 → $27
Current: $1.98
Upside: +1,263.64%
Zimmer Biomet Holdings
Feb 8, 2022
Maintains: Underweight
Price Target: $124 → $111
Current: $101.14
Upside: +9.75%
Jan 19, 2022
Upgrades: Overweight
Price Target: $144
Current: $69.23
Upside: +107.64%
Jan 19, 2022
Upgrades: Equal-Weight
Price Target: $56
Current: $77.79
Upside: -28.01%
Oct 29, 2021
Maintains: Equal-Weight
Price Target: $68 → $74
Current: $82.75
Upside: -10.57%
Apr 28, 2020
Downgrades: Equal-Weight
Price Target: $77
Current: $82.19
Upside: -6.72%
Mar 5, 2020
Upgrades: Overweight
Price Target: $85 → $90
Current: $13.37
Upside: +573.15%
Dec 12, 2019
Upgrades: Overweight
Price Target: n/a
Current: $62.75
Upside: -